Innovation Update

Weekend Reading: More Churning

Stock quotes in this article: GM , SU , VIA , XOM , K , CVX , PFE  

Good Sunday morning, and welcome to another edition of Weekend Reading. First, a look back at the week that just finished, then a look forward to the week ahead and, finally, a summary of articles and papers worth reading.

It was the first down week in ages for most of the major markets, even if the Nasdaq didn't go along. (See table below.) Nervousness about banks, weak earnings and a slowing of recent gains -- which have taken the markets up 25%-plus -- were all causes.

Next week looks like more of the churning same. We face more earnings reports, more chatter around the bank stress tests, a teetering auto sector, capital raises and a host of economic indicators. While that doesn't mean that the market will weaken materially, it does mean -- when combined with much higher equity levels -- that we likely will churn in place for a spell.

Turning to economic indicators, next week we will see the S&P/Case-Shiller home price index, the Conference Board's April consumer confidence reading and the first-quarter GDP number. Other data set to be released include weekly jobless claims, March personal income and spending, and a report from the Institute for Supply Management on manufacturing activity.

As for earnings, the coming week will bring reports from Exxon Mobil(XOM Quote), Chevron(CVX Quote), Pfizer(PFE Quote), Verizon(VZ Quote), Procter & Gamble(PG Quote), Viacom(VIA Quote), Clorox(CLX Quote), Kellogg(K Quote) and Colgate-Palmolive(CL Quote).

Finally, here are some articles and papers worth reading:

Editor's note: To access some of these stories, registration or a subscription may be required. Please check the individual links for each site's policy.

RealMoney Barometer Poll
1 What would best describe your stance heading into the coming week of trading?
Bullish
Bearish
Neutral
2 Which of these sectors do you think is set to move up in the coming week?
3 Which of these sectors do you think is set to move down in the coming week?


View the results without voting
  • Loading Comments...
  •  

SHARE:

  • email
  • print
  • comment
  • digg
  • delicious
  • linkedin
At time of publication, Kedrosky had no positions in stocks mentioned, although holdings can change at any time.

Dr. Paul Kedrosky is a former highly ranked sell-side technology equity analyst, and he currently runs a technology finance institute at the University of California, San Diego. He is also a venture partner with Ventures West, an institutional venture capital firm with more than $400 million under management. He maintains a widely read blog called Infectious Greed.

Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. While Kedrosky cannot provide investment advice or recommendations, he appreciates your feedback; click here to send him an email.

Recent Comments





Connect with TheStreet

Dow Jones S&P 500 NASDAQ 10-Year Note
10,501.05 1,114.11 2,212.10 35.46
Oil *
71.84
UP
29.55
UP
7.70
UP
21.79
UP
0.06
10 Yr
3.55%
SPDR Gold
110.24
+0.28%
+0.70%
+0.99%
+0.17%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services